Blueprint Medicines
BPMC
#2452
Rank
ยฃ4.62 B
Marketcap
ยฃ72.83
Share price
-4.87%
Change (1 day)
5.17%
Change (1 year)

Revenue for Blueprint Medicines (BPMC)

Revenue in 2024 (TTM): ยฃ0.33 Billion

According to Blueprint Medicines 's latest financial reports the company's current revenue (TTM ) is ยฃ0.34 Billion. In 2023 the company made a revenue of ยฃ0.19 Billion an increase over the revenue in the year 2022 that were of ยฃ0.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Blueprint Medicines from 2015 to 2024

201620192022ยฃ0.1Bยฃ0.2Bยฃ0.3Bยฃ0.4Bยฃ0.5Bยฃ0.6Bcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.33 B72.46%
2023 ยฃ0.19 B16.06%
2022 ยฃ0.16 B26.42%
2021 ยฃ0.13 B-77.09%
2020 ยฃ0.58 B1048.05%
2019 ยฃ50.72 M44.62%
2018 ยฃ35.07 M121.24%
2017 ยฃ15.85 M-29.56%
2016 ยฃ22.5 M192.58%
2015 ยฃ7.69 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ7.11 M-97.94%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.56 B 63.76%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.13 B-60.14%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ89.48 M-74.04%๐Ÿ‡บ๐Ÿ‡ธ USA